Maravai LifeSciences Holdings Inc (MRVI)
7.445
-0.22
(-2.93%)
USD |
NASDAQ |
Apr 25, 11:31
Maravai LifeSciences Holdings Total Liabilities (Quarterly): 697.57M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 697.57M |
| September 30, 2023 | 1.375B |
| June 30, 2023 | 1.367B |
| March 31, 2023 | 1.415B |
| December 31, 2022 | 1.377B |
| September 30, 2022 | 1.407B |
| June 30, 2022 | 1.398B |
| March 31, 2022 | 1.389B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.373B |
| September 30, 2021 | 1.441B |
| June 30, 2021 | 1.268B |
| March 31, 2021 | 1.142B |
| December 31, 2020 | 1.116B |
| September 30, 2020 | 702.12M |
| December 31, 2019 | 433.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
433.17M
Minimum
Dec 2019
1.441B
Maximum
Sep 2021
1.193B
Average
1.373B
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| ModivCare Inc | 1.611B |
| Dyadic International Inc | 2.341M |
| Enveric Biosciences Inc | 2.344M |
| Monopar Therapeutics Inc | 1.757M |
| SeaStar Medical Holding Corp | 17.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.487B |
| Shareholders Equity (Quarterly) | 416.75M |
| Debt to Equity Ratio | 1.258 |
| Current Ratio | 8.002 |
| Net Debt Paydown Yield | 0.10% |